Correlation Between Edgewise Therapeutics and Abeona Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Abeona Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Abeona Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Abeona Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Edgewise and Abeona is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Abeona Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Abeona Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Abeona Therapeutics. In addition to that, Edgewise Therapeutics is 1.22 times more volatile than Abeona Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Abeona Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest 561.00 in Abeona Therapeutics on December 29, 2024 and sell it today you would lose (64.00) from holding Abeona Therapeutics or give up 11.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Abeona Therapeutics
Performance |
Timeline |
Edgewise Therapeutics |
Abeona Therapeutics |
Edgewise Therapeutics and Abeona Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Abeona Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Abeona Therapeutics vs. Reviva Pharmaceuticals Holdings | Abeona Therapeutics vs. Athira Pharma | Abeona Therapeutics vs. Fortress Biotech | Abeona Therapeutics vs. ACADIA Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |